RiboX Therapeutics
Cambridge, Massachusetts, United States
Edo Kon is the Director of Business Development at RiboX Therapeutics, where he leverages his background in biotechnology and strategic planning to identify emerging trends, novel therapeutic opportunities and drive partnerships.
Before this, he served as the Principal Scientist of Lipid Nanoparticle (LNP) Science at RiboX Therapeutics. He founded and led the LNP research teams to develop novel formulations and strategies for circular RNA delivery.
He is the author of multiple high-impact manuscripts that focus on RNA delivery. He holds a PhD and an MBA from Tel Aviv University.
Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): RiboX Therapeutics: Employee (Ongoing)
